Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes

Stanislav Sitkin^{1

2

3}, Timur Vakhitov², Juris Pokrotnieks^{4

5}

Affiliations

¹ Department of Internal Diseases, Gastroenterology and Dietetics, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia.
² Department of Microbiology, State Research Institute of Highly Pure Biopreparations, St. Petersburg, Russia.
³ Institute of Perinatology and Pediatrics, Almazov National Medical Research Centre, St. Petersburg, Russia.
⁴ Department of Internal Diseases, Rīga Stradiņš University, Riga, Latvia.
⁵ Centre of Gastroenterology, Hepatology and Nutrition, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.

Comment

Stanislav Sitkin et al. Neurogastroenterol Motil. 2021 Jan.

. 2021 Jan;33(1):e14038.

doi: 10.1111/nmo.14038. Epub 2020 Nov 22.

Stanislav Sitkin^{1

2

3}, Timur Vakhitov², Juris Pokrotnieks^{4

5}

¹ Department of Internal Diseases, Gastroenterology and Dietetics, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia.
² Department of Microbiology, State Research Institute of Highly Pure Biopreparations, St. Petersburg, Russia.
³ Institute of Perinatology and Pediatrics, Almazov National Medical Research Centre, St. Petersburg, Russia.
⁴ Department of Internal Diseases, Rīga Stradiņš University, Riga, Latvia.
⁵ Centre of Gastroenterology, Hepatology and Nutrition, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.

No abstract available

Comment in

Reply Letter to "Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes".
Facchin S, Buda A, Savarino E. Facchin S, et al. Neurogastroenterol Motil. 2021 Jan;33(1):e14054. doi: 10.1111/nmo.14054. Epub 2020 Dec 4. Neurogastroenterol Motil. 2021. PMID: 33274806 No abstract available.

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
Facchin S, Vitulo N, Calgaro M, Buda A, Romualdi C, Pohl D, Perini B, Lorenzon G, Marinelli C, D'Incà R, Sturniolo GC, Savarino EV. Facchin S, et al. Neurogastroenterol Motil. 2020 Oct;32(10):e13914. doi: 10.1111/nmo.13914. Epub 2020 May 31. Neurogastroenterol Motil. 2020. PMID: 32476236 Free PMC article. Clinical Trial.